NCT04070755View on ClinicalTrials.gov

Dermal Photo Allergic Skin Reaction

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

September 21, 2016

Primary Completion Date

November 18, 2016

Study Completion Date

December 18, 2016

Conditions

Healthy

Interventions

DRUG

FMX-101

All Listed Sponsors

lead

Vyne Therapeutics Inc.

INDUSTRY

NCT04070755 - Dermal Photo Allergic Skin Reaction | Biotech Hunter | Biotech Hunter